Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.43)
# 3,593
Out of 5,149 analysts
177
Total ratings
44%
Success rate
-2.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $5.26 | +52.09% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $125.85 | +62.89% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $96.71 | +20.98% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $97.97 | -3.03% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $497.42 | +30.67% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.71 | +23.58% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $148.00 | -35.81% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $83.08 | +2.31% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $38.62 | -61.16% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $241.84 | +41.83% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.53 | +815.03% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $19.03 | +152.23% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $85.28 | +19.61% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $73.85 | -21.46% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $17.98 | +11.23% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $73.08 | +79.26% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $113.61 | +17.07% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $384.59 | -42.80% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $122.19 | +209.35% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $5.26
Upside: +52.09%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $125.85
Upside: +62.89%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $96.71
Upside: +20.98%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $97.97
Upside: -3.03%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $497.42
Upside: +30.67%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.71
Upside: +23.58%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $148.00
Upside: -35.81%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $83.08
Upside: +2.31%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $38.62
Upside: -61.16%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $241.84
Upside: +41.83%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.53
Upside: +815.03%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $19.03
Upside: +152.23%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $85.28
Upside: +19.61%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $73.85
Upside: -21.46%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $17.98
Upside: +11.23%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $73.08
Upside: +79.26%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $113.61
Upside: +17.07%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $384.59
Upside: -42.80%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $122.19
Upside: +209.35%